Remarkably, combinatorial anti-tumor strategies employing GOLPH3 knockdown have already been proven effective in glioma [72,73], colon cancer [74,75], and oral squamous cell carcinoma [76]. This evidence concerns the gene GOLPH3 and neoplasm.